Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia-Reference-Cited by-同舟云学术

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia

Published:2022-07 Issue: Volume:Volume 14 Page:49-59
ISSN:1179-1438
Container-title:Clinical Pharmacology: Advances and Applications
language:en
Short-container-title:CPAA

Author:

Kosmas Constantine E,Bousvarou Maria D,Sourlas Andreas,Papakonstantinou Evangelia J,Peña Genao Edilberto,Echavarria Uceta Rogers,Guzman Eliscer

Publisher

Informa UK Limited

Subject

Pharmacology (medical)

Reference48 articles.

1. World Health Organization. Cardiovascular diseases (CVDs). Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed March 10, 2022.

2. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

3. Pathogenesis of Atherosclerosis

4. Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions

5. Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to treat primary hyperlipidemia;American Journal of Biopharmacy and Pharmaceutical Sciences;2024-08-01

2. The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies;Metabolites;2024-07-17

3. Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives;Current Atherosclerosis Reports;2024-07-15

4. Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy;European Heart Journal;2024-06-10

5. ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05